Search International and National Patent Collections

1. (WO2001037831) PHARMACEUTICAL COMBINATION COMPRISING SEPARATE DOSAGE FORMS IN A COMPLIANCE PACKAGE OF AN INHIBITOR OF HMG CoA REDUCTASE AND FIBRIC ACID DERIVATIVE

Pub. No.:    WO/2001/037831    International Application No.:    PCT/GR2000/000032
Publication Date: Fri Jun 01 01:59:59 CEST 2001 International Filing Date: Thu Nov 09 00:59:59 CET 2000
IPC: A61K 31/365
A61K 31/40
A61K 31/405
Applicants: SPYRIOUNIS, Demetrius
ALEXIDIS, Alexandros
Inventors: SPYRIOUNIS, Demetrius
ALEXIDIS, Alexandros
Title: PHARMACEUTICAL COMBINATION COMPRISING SEPARATE DOSAGE FORMS IN A COMPLIANCE PACKAGE OF AN INHIBITOR OF HMG CoA REDUCTASE AND FIBRIC ACID DERIVATIVE
Abstract:
The present invention relates to a pharmaceutical combination comprising an inhibitor of the enzyme 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase (statin), which is simvastatin, fluvastatin, atorvastatin or cerivastatin and a fibric acid derivative (fibrate), which is fenofibrate, ciprofibrate or bezafibrate, and to a method of administering these medicaments for the treatment of dyslipidemia (especially mixed hyperlipidemia and familial combined hyperlipidemia) in diabetics and non-diabetics.